JACC: CardioOncology Oncology

Immune Responses in Checkpoint Inhibitor–Associated Cardiovascular Immune–Related Adverse Events: JACC: CardioOncology State-of-the-Art Review

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →